Ignite Creation Date:
2024-05-05 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00104871
Status:
COMPLETED
Last Update Posted:
2018-12-19
First Post:
2005-03-03
Brief Title:
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Papillary Thyroid Cancer |
| Insular Thyroid Cancer |
| Recurrent Thyroid Cancer |
| Stage II Follicular Thyroid Cancer |
| Stage II Papillary Thyroid Cancer |
| Stage IV Follicular Thyroid Cancer |
Keywords:
| Name | View |
|---|---|
| tall cell | View |
| National Thyroid Cancer Treatment Cooperative Study Group | View |
| NTCTCSG | View |
| bortezomib | View |
| velcade | View |
| metastatic differentiated thyroid carcinoma | View |
| Differentiated thyroid carcinoma | View |
| follicular epithelial thyroid cells | View |
| papillary | View |
| oxyphilic cell | View |
| Hurthle cell | View |
| insular cell | View |
| columnar cell | View |